Leads Biolabs-b 9887.HK
9887.HK
Leads Biolabs-b 9966.HK
Alphamab Oncology 2157.HK
Lepu Biopharma Co., Ltd. 2591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2616.HK
CStone Pharmaceuticals 0570.HK
China Traditional Chinese Medicine Holdings Co. Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2142.HK
HBM Holdings Limited 0775.HK
CK Life Sciences Int'l., (Holdings) Inc.
Leads Biolabs-b 9966.HK
Alphamab Oncology 2157.HK
Lepu Biopharma Co., Ltd. 2591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2616.HK
CStone Pharmaceuticals 0570.HK
China Traditional Chinese Medicine Holdings Co. Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2142.HK
HBM Holdings Limited 0775.HK
CK Life Sciences Int'l., (Holdings) Inc.
Performance
| Periode | 9887.HK | 9966.HK | 2157.HK | 2591.HK | 6826.HK | 2616.HK | 0570.HK | 2171.HK | 2142.HK | 0775.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -2.61 % | 92.24 % | 54.61 % | -39.74 % | 10.35 % | 158.70 % | 26.87 % | 14.86 % | 61.16 % | 18.42 % |
| YTD | -2.61 % | 290.09 % | 159.52 % | -39.74 % | 4.53 % | 191.43 % | 13.33 % | 81.24 % | 560.10 % | 119.51 % |
| 1Y | -2.61 % | 248.44 % | 110.29 % | -39.74 % | -20.48 % | 296.67 % | 2.82 % | 323.94 % | 929.13 % | 87.50 % |
| 3Y | -2.61 % | 116.50 % | -12.33 % | -39.74 % | 61.50 % | 85.45 % | -21.54 % | 25.18 % | 1 036.52 % | 45.16 % |
| 5Y | -2.61 % | -15.95 % | -8.40 % | -39.74 % | -20.29 % | -38.02 % | -24.33 % | -43.33 % | 18.60 % | 2.27 % |
| 10Y | -2.61 % | -0.89 % | -8.40 % | -39.74 % | -14.94 % | -44.48 % | -56.34 % | -43.33 % | 18.60 % | 23.29 % |
| From the beginning | -2.61 % | -0.89 % | -8.40 % | -39.74 % | -35.84 % | -44.48 % | 363.64 % | -43.33 % | 18.60 % | -69.05 % |